Antineutrophil cytoplasmic autoantibodies.
The identification of ANCA and their association with systemic vascular inflammation has become quite useful in both the diagnosis and management of patients with necrotizing vasculitic conditions. Primary autoantibody specificities have been identified, and many more await further characterization. As with ANA, it is highly probable that ANCA will not only complement patient care, but will provide means helpful in exploring the molecular structures and biochemical pathways within granulocytic phagocytes.